Aquestive Therapeutics, Inc. (AQST)
Makes dissolvable film medications for seizures, opioid addiction, and ADHD.
$3.76+0.01%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-1.6%
The outlook
AQST is trading near its 52-week lows and below both its 50- and 200-day moving averages, reflecting a bearish near-term trend. Analyst coverage shows a notably bullish average price target around 136% above the current price, though the overall StockGlow sentiment leans bearish. The stock remains depressed relative to its recent range.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range18% of the way from its 52-week low to high
Price targetAvg target +136% vs current price
Analyst price target
~12-month · 9 analysts$8.89average target+136.4% vs now
Now $3.76
Low $6.00High $11.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$471.8M
52-wk high
$7.55
52-wk low
$2.93
50-day avg
$4.17
200-day avg
$4.75
Trailing P/E
—